nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.168	0.282	CbGbCtD
Thiotepa—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.114	0.19	CbGbCtD
Thiotepa—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.108	0.182	CbGbCtD
Thiotepa—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0967	0.162	CbGbCtD
Thiotepa—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0567	0.0949	CbGbCtD
Thiotepa—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0536	0.0897	CbGbCtD
Thiotepa—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000843	0.0021	CcSEcCtD
Thiotepa—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000832	0.00207	CcSEcCtD
Thiotepa—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000828	0.00206	CcSEcCtD
Thiotepa—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000824	0.00205	CcSEcCtD
Thiotepa—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000822	0.00205	CcSEcCtD
Thiotepa—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000822	0.00205	CcSEcCtD
Thiotepa—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000812	0.00202	CcSEcCtD
Thiotepa—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000807	0.00201	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000803	0.002	CcSEcCtD
Thiotepa—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00199	CcSEcCtD
Thiotepa—Agitation—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00199	CcSEcCtD
Thiotepa—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000799	0.00199	CcSEcCtD
Thiotepa—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000796	0.00198	CcSEcCtD
Thiotepa—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000791	0.00197	CcSEcCtD
Thiotepa—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000784	0.00195	CcSEcCtD
Thiotepa—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000775	0.00193	CcSEcCtD
Thiotepa—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000764	0.0019	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00076	0.00189	CcSEcCtD
Thiotepa—Cough—Formoterol—chronic obstructive pulmonary disease	0.00076	0.00189	CcSEcCtD
Thiotepa—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.00189	CcSEcCtD
Thiotepa—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000756	0.00188	CcSEcCtD
Thiotepa—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000753	0.00187	CcSEcCtD
Thiotepa—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000752	0.00187	CcSEcCtD
Thiotepa—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000752	0.00187	CcSEcCtD
Thiotepa—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000749	0.00186	CcSEcCtD
Thiotepa—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000745	0.00185	CcSEcCtD
Thiotepa—Cough—Montelukast—chronic obstructive pulmonary disease	0.000744	0.00185	CcSEcCtD
Thiotepa—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000744	0.00185	CcSEcCtD
Thiotepa—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000742	0.00185	CcSEcCtD
Thiotepa—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00185	CcSEcCtD
Thiotepa—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00185	CcSEcCtD
Thiotepa—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00185	CcSEcCtD
Thiotepa—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00185	CcSEcCtD
Thiotepa—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000739	0.00184	CcSEcCtD
Thiotepa—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000739	0.00184	CcSEcCtD
Thiotepa—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000739	0.00184	CcSEcCtD
Thiotepa—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000738	0.00184	CcSEcCtD
Thiotepa—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000738	0.00184	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000736	0.00183	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000736	0.00183	CcSEcCtD
Thiotepa—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000726	0.00181	CcSEcCtD
Thiotepa—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000726	0.00181	CcSEcCtD
Thiotepa—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000724	0.0018	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000721	0.00179	CcSEcCtD
Thiotepa—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00072	0.00179	CcSEcCtD
Thiotepa—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.00179	CcSEcCtD
Thiotepa—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000717	0.00178	CcSEcCtD
Thiotepa—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00071	0.00177	CcSEcCtD
Thiotepa—Infection—Formoterol—chronic obstructive pulmonary disease	0.000706	0.00176	CcSEcCtD
Thiotepa—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000706	0.00176	CcSEcCtD
Thiotepa—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.0007	0.00174	CcSEcCtD
Thiotepa—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.0007	0.00174	CcSEcCtD
Thiotepa—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0007	0.00174	CcSEcCtD
Thiotepa—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000698	0.00174	CcSEcCtD
Thiotepa—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000698	0.00174	CcSEcCtD
Thiotepa—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000697	0.00173	CcSEcCtD
Thiotepa—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000697	0.00173	CcSEcCtD
Thiotepa—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000696	0.00173	CcSEcCtD
Thiotepa—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000694	0.00173	CcSEcCtD
Thiotepa—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000694	0.00173	CcSEcCtD
Thiotepa—Infection—Montelukast—chronic obstructive pulmonary disease	0.000692	0.00172	CcSEcCtD
Thiotepa—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000691	0.00172	CcSEcCtD
Thiotepa—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000691	0.00172	CcSEcCtD
Thiotepa—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000688	0.00171	CcSEcCtD
Thiotepa—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000683	0.0017	CcSEcCtD
Thiotepa—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000682	0.0017	CcSEcCtD
Thiotepa—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00068	0.00169	CcSEcCtD
Thiotepa—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000676	0.00168	CcSEcCtD
Thiotepa—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000667	0.00166	CcSEcCtD
Thiotepa—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000661	0.00164	CcSEcCtD
Thiotepa—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000658	0.00164	CcSEcCtD
Thiotepa—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.00163	CcSEcCtD
Thiotepa—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00162	CcSEcCtD
Thiotepa—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000649	0.00161	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.00161	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000648	0.00161	CcSEcCtD
Thiotepa—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00064	0.00159	CcSEcCtD
Thiotepa—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000639	0.00159	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000634	0.00158	CcSEcCtD
Thiotepa—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00157	CcSEcCtD
Thiotepa—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00157	CcSEcCtD
Thiotepa—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000626	0.00156	CcSEcCtD
Thiotepa—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000626	0.00156	CcSEcCtD
Thiotepa—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00156	CcSEcCtD
Thiotepa—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000623	0.00155	CcSEcCtD
Thiotepa—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000619	0.00154	CcSEcCtD
Thiotepa—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000618	0.00154	CcSEcCtD
Thiotepa—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000616	0.00153	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000614	0.00153	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000614	0.00153	CcSEcCtD
Thiotepa—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000613	0.00152	CcSEcCtD
Thiotepa—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000613	0.00152	CcSEcCtD
Thiotepa—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.00152	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.00152	CcSEcCtD
Thiotepa—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000608	0.00151	CcSEcCtD
Thiotepa—Pain—Formoterol—chronic obstructive pulmonary disease	0.000608	0.00151	CcSEcCtD
Thiotepa—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.00151	CcSEcCtD
Thiotepa—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.00151	CcSEcCtD
Thiotepa—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000603	0.0015	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000601	0.0015	CcSEcCtD
Thiotepa—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.0006	0.00149	CcSEcCtD
Thiotepa—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00148	CcSEcCtD
Thiotepa—Pain—Montelukast—chronic obstructive pulmonary disease	0.000595	0.00148	CcSEcCtD
Thiotepa—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000594	0.00148	CcSEcCtD
Thiotepa—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000591	0.00147	CcSEcCtD
Thiotepa—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000589	0.00147	CcSEcCtD
Thiotepa—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000588	0.00146	CcSEcCtD
Thiotepa—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000587	0.00146	CcSEcCtD
Thiotepa—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000586	0.00146	CcSEcCtD
Thiotepa—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000586	0.00146	CcSEcCtD
Thiotepa—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000585	0.00146	CcSEcCtD
Thiotepa—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.00145	CcSEcCtD
Thiotepa—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000583	0.00145	CcSEcCtD
Thiotepa—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000582	0.00145	CcSEcCtD
Thiotepa—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000581	0.00145	CcSEcCtD
Thiotepa—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000581	0.00145	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00058	0.00144	CcSEcCtD
Thiotepa—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000579	0.00144	CcSEcCtD
Thiotepa—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000574	0.00143	CcSEcCtD
Thiotepa—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000574	0.00143	CcSEcCtD
Thiotepa—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000569	0.00142	CcSEcCtD
Thiotepa—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000565	0.00141	CcSEcCtD
Thiotepa—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000565	0.00141	CcSEcCtD
Thiotepa—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000562	0.0014	CcSEcCtD
Thiotepa—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.0014	CcSEcCtD
Thiotepa—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000562	0.0014	CcSEcCtD
Thiotepa—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000562	0.0014	CcSEcCtD
Thiotepa—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00056	0.00139	CcSEcCtD
Thiotepa—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000555	0.00138	CcSEcCtD
Thiotepa—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000555	0.00138	CcSEcCtD
Thiotepa—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00138	CcSEcCtD
Thiotepa—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000553	0.00138	CcSEcCtD
Thiotepa—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000553	0.00138	CcSEcCtD
Thiotepa—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000552	0.00137	CcSEcCtD
Thiotepa—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00055	0.00137	CcSEcCtD
Thiotepa—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00055	0.00137	CcSEcCtD
Thiotepa—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000549	0.00137	CcSEcCtD
Thiotepa—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.00136	CcSEcCtD
Thiotepa—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000542	0.00135	CcSEcCtD
Thiotepa—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000541	0.00135	CcSEcCtD
Thiotepa—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000533	0.00133	CcSEcCtD
Thiotepa—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.00132	CcSEcCtD
Thiotepa—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000531	0.00132	CcSEcCtD
Thiotepa—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000524	0.0013	CcSEcCtD
Thiotepa—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000524	0.0013	CcSEcCtD
Thiotepa—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000523	0.0013	CcSEcCtD
Thiotepa—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000513	0.00128	CcSEcCtD
Thiotepa—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00127	CcSEcCtD
Thiotepa—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00127	CcSEcCtD
Thiotepa—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000503	0.00125	CcSEcCtD
Thiotepa—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000503	0.00125	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000502	0.00125	CcSEcCtD
Thiotepa—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00124	CcSEcCtD
Thiotepa—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000495	0.00123	CcSEcCtD
Thiotepa—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000493	0.00123	CcSEcCtD
Thiotepa—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.00121	CcSEcCtD
Thiotepa—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000486	0.00121	CcSEcCtD
Thiotepa—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000484	0.0012	CcSEcCtD
Thiotepa—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.0012	CcSEcCtD
Thiotepa—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00119	CcSEcCtD
Thiotepa—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000475	0.00118	CcSEcCtD
Thiotepa—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000472	0.00117	CcSEcCtD
Thiotepa—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00047	0.00117	CcSEcCtD
Thiotepa—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00047	0.00117	CcSEcCtD
Thiotepa—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00115	CcSEcCtD
Thiotepa—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00114	CcSEcCtD
Thiotepa—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00112	CcSEcCtD
Thiotepa—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00112	CcSEcCtD
Thiotepa—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00112	CcSEcCtD
Thiotepa—Rash—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00112	CcSEcCtD
Thiotepa—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00111	CcSEcCtD
Thiotepa—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00111	CcSEcCtD
Thiotepa—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00111	CcSEcCtD
Thiotepa—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000445	0.00111	CcSEcCtD
Thiotepa—Headache—Formoterol—chronic obstructive pulmonary disease	0.000445	0.00111	CcSEcCtD
Thiotepa—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000445	0.00111	CcSEcCtD
Thiotepa—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.0011	CcSEcCtD
Thiotepa—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000444	0.0011	CcSEcCtD
Thiotepa—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000443	0.0011	CcSEcCtD
Thiotepa—Rash—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00109	CcSEcCtD
Thiotepa—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00109	CcSEcCtD
Thiotepa—Headache—Montelukast—chronic obstructive pulmonary disease	0.000436	0.00109	CcSEcCtD
Thiotepa—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00106	CcSEcCtD
Thiotepa—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00105	CcSEcCtD
Thiotepa—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00105	CcSEcCtD
Thiotepa—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00105	CcSEcCtD
Thiotepa—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00105	CcSEcCtD
Thiotepa—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00105	CcSEcCtD
Thiotepa—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000414	0.00103	CcSEcCtD
Thiotepa—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.00102	CcSEcCtD
Thiotepa—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000407	0.00101	CcSEcCtD
Thiotepa—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.000992	CcSEcCtD
Thiotepa—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000396	0.000985	CcSEcCtD
Thiotepa—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000394	0.00098	CcSEcCtD
Thiotepa—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000392	0.000975	CcSEcCtD
Thiotepa—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000387	0.000963	CcSEcCtD
Thiotepa—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.000935	CcSEcCtD
Thiotepa—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000368	0.000916	CcSEcCtD
Thiotepa—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000357	0.000889	CcSEcCtD
Thiotepa—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000356	0.000885	CcSEcCtD
Thiotepa—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000352	0.000875	CcSEcCtD
Thiotepa—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000866	CcSEcCtD
Thiotepa—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.00086	CcSEcCtD
Thiotepa—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000858	CcSEcCtD
Thiotepa—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000343	0.000853	CcSEcCtD
Thiotepa—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000343	0.000853	CcSEcCtD
Thiotepa—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.000819	CcSEcCtD
Thiotepa—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000323	0.000804	CcSEcCtD
Thiotepa—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.000789	CcSEcCtD
Thiotepa—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000788	CcSEcCtD
Thiotepa—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000784	CcSEcCtD
Thiotepa—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000306	0.000761	CcSEcCtD
Thiotepa—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000297	0.000739	CcSEcCtD
Thiotepa—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000296	0.000736	CcSEcCtD
Thiotepa—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000726	CcSEcCtD
Thiotepa—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000726	CcSEcCtD
Thiotepa—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000291	0.000724	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00029	0.000721	CcSEcCtD
Thiotepa—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000284	0.000706	CcSEcCtD
Thiotepa—Infection—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000692	CcSEcCtD
Thiotepa—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000274	0.000683	CcSEcCtD
Thiotepa—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000679	CcSEcCtD
Thiotepa—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000676	CcSEcCtD
Thiotepa—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000663	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000634	CcSEcCtD
Thiotepa—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.000633	CcSEcCtD
Thiotepa—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000625	CcSEcCtD
Thiotepa—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000613	CcSEcCtD
Thiotepa—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000605	CcSEcCtD
Thiotepa—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.000604	CcSEcCtD
Thiotepa—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000243	0.000603	CcSEcCtD
Thiotepa—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000241	0.0006	CcSEcCtD
Thiotepa—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.0006	CcSEcCtD
Thiotepa—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000595	CcSEcCtD
Thiotepa—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000574	CcSEcCtD
Thiotepa—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000569	CcSEcCtD
Thiotepa—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000569	CcSEcCtD
Thiotepa—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000553	CcSEcCtD
Thiotepa—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00055	CcSEcCtD
Thiotepa—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00055	CcSEcCtD
Thiotepa—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000513	CcSEcCtD
Thiotepa—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000499	CcSEcCtD
Thiotepa—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000492	CcSEcCtD
Thiotepa—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000476	CcSEcCtD
Thiotepa—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00046	CcSEcCtD
Thiotepa—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000443	CcSEcCtD
Thiotepa—Rash—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000439	CcSEcCtD
Thiotepa—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000438	CcSEcCtD
Thiotepa—Headache—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000436	CcSEcCtD
Thiotepa—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000413	CcSEcCtD
Thiotepa—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	5.42e-05	0.12	CbGpPWpGaD
Thiotepa—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	4.8e-05	0.106	CbGpPWpGaD
Thiotepa—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	3.92e-05	0.0866	CbGpPWpGaD
Thiotepa—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	1.99e-05	0.044	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.0418	CbGpPWpGaD
Thiotepa—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	1.53e-05	0.0337	CbGpPWpGaD
Thiotepa—CYP2B6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.0304	CbGpPWpGaD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.0273	CbGpPWpGaD
Thiotepa—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	1.18e-05	0.0261	CbGpPWpGaD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	1.03e-05	0.0227	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	9.35e-06	0.0207	CbGpPWpGaD
Thiotepa—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	8.96e-06	0.0198	CbGpPWpGaD
Thiotepa—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	8.6e-06	0.019	CbGpPWpGaD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	8.27e-06	0.0183	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.04e-06	0.0178	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.86e-06	0.0174	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.75e-06	0.0171	CbGpPWpGaD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	7.47e-06	0.0165	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	7.17e-06	0.0158	CbGpPWpGaD
Thiotepa—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	6.8e-06	0.015	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	6.37e-06	0.0141	CbGpPWpGaD
Thiotepa—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	6.25e-06	0.0138	CbGpPWpGaD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	6.01e-06	0.0133	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.71e-06	0.0126	CbGpPWpGaD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.63e-06	0.0124	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	5.62e-06	0.0124	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.63e-06	0.0102	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	4.42e-06	0.00975	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.07e-06	0.00899	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.02e-06	0.00889	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	3.65e-06	0.00807	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	3.57e-06	0.00789	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	3.52e-06	0.00778	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.38e-06	0.00747	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.34e-06	0.00737	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	3.21e-06	0.00709	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	2.89e-06	0.00639	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.82e-06	0.00623	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.78e-06	0.00615	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	2.59e-06	0.00573	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.59e-06	0.00573	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	2.56e-06	0.00565	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.56e-06	0.00565	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.46e-06	0.00543	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.42e-06	0.00536	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.1e-06	0.00465	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	1.98e-06	0.00437	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.85e-06	0.00409	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.83e-06	0.00404	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.54e-06	0.0034	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.52e-06	0.00335	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.31e-06	0.00289	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.28e-06	0.00283	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	1.27e-06	0.00282	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.26e-06	0.00279	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.18e-06	0.00262	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.18e-06	0.0026	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.16e-06	0.00257	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.12e-06	0.00247	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.1e-06	0.00243	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	8.99e-07	0.00199	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.96e-07	0.00154	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.88e-07	0.00152	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.28e-07	0.00139	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.95e-07	0.00131	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	5.79e-07	0.00128	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.79e-07	0.00128	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.38e-07	0.00119	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.83e-07	0.00107	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.76e-07	0.00105	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.43e-07	0.00098	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.2e-07	0.000929	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.16e-07	0.000699	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.13e-07	0.000691	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	2.86e-07	0.000631	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.85e-07	0.00063	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.73e-07	0.000604	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.63e-07	0.000581	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.19e-07	0.000484	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.16e-07	0.000478	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.02e-07	0.000445	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.91e-07	0.000422	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.3e-07	0.000287	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.24e-07	0.000274	CbGpPWpGaD
